arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Myseum.AI, Inc.

MYSE

$2.58 ▲ +0.14 (+5.74%) at close

7 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Myseum.AI, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $10.8M

Dividend Yield —

Revenue Growth 26.1% ↗

Op. Margin —

ROIC -71.0% ↘

FCF / Share $-1.02 ↗

Trailing P/E —

Price / Book 1.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$550.00

↑ +26.1% —

Net Income Profit after all expenses

$-2.61M

↑ +38.5% —

FCF / Share Free cash flow per share

$-1.02

↑ +37.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	26.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+227%)	-35.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-539%)	-98.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1332%)	939.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11646%)	—	—	—
EPS Growth YoY (%)	56.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	31.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-750.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	38.5% Excellent ↑ Excellent Improving Year-over-year change in net income	49.6% Excellent ↑ Excellent Improving Year-over-year change in net income	30.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.1% Weak Weak Year-over-year change in net income	-1005.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	37.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	49.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	10.7% Fair Fair Year-over-year change in free cash flow	-554.5% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	-77.2% Weak Weak Compound annual revenue growth over 3 years	-53.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	1.64x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-71.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-113.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-42.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-76.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-59.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-135.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-93.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-52.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-42.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-456%)	-61.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-614%)	-137.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1248%)	-96.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-906%)	-53.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-549%)	-168.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1502%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-7300.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-85342.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-749.03K	$-766.99K	$-953.36K	$-1.73M	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.00	$0.02	$0.00	—	—
Basic EPS, GAAP (USD)	$-0.62	$-1.43	$-4.14	$-6.04	$-0.71	—	—
Free Cash Flow per Share (USD)	$-1.02	$-1.63	$-3.24	$-3.63	$-0.55	—	—
Book Value per Share (USD)	$1.43	$2.29	$3.00	$6.10	$1.02	$0.05	—
Tangible Book Value per Share (USD)	$1.43	$2.29	$3.00	$6.10	$1.02	$0.05	—
Basic Weighted Avg Shares (shares)	4.20M	2.96M	2.03M	2.01M	15.33M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$3.05M	$3.66M	$5.97M	$12.40M	$20.00M	$555.69K	—
Total Equity (USD)	$6.10M	$6.88M	$6.10M	$12.56M	$20.08M	$582.33K	$-339.88K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$550.00	$436.00	$672.00	$46.21K	$4.45K	—	—
Depreciation Expense (USD)	$20.54K	$23.13K	—	$127.50K	—	—	—
Net Income, GAAP (USD)	$-2.61M	$-4.24M	$-8.40M	$-12.14M	$-10.83M	$-979.47K	—
Operating Cash Flow (USD)	$-4.27M	$-4.81M	$-6.53M	$-7.26M	$-8.45M	$-1.10M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Myseum.AI, Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MYSE with peers